Drug intelligence / Profile preview

Huaijiao Pill

Development stage: Unknown
Lead developer: Shandong Wohua Pharmaceutical
Administration: Oral

Overview

Huaijiao Pill is a traditional Chinese medicine (TCM) formulation developed and marketed by Shandong Wohua Pharmaceutical Polytron Technologies. It is provided in pill form for oral administration and is primarily indicated for the treatment of hemorrhoids and associated rectal bleeding. The formulation is a complex mixture of herbal ingredients, with scientific analysis identifying bioactive markers such as sophoricoside, baicalin, naringin, genistein, rutin, quercetin, and 5-O-methylvisammioside. In the framework of traditional Chinese medicine, it functions to clear heat, cool the blood, and stop bleeding. It is an approved product in China and is part of Shandong Wohua's portfolio of traditional Chinese patent medicines.

Brand names: Huaijiao Pill槐角丸
Other names: Huaijiao Wan

Beyond the preview

Go deeper on Huaijiao Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huaijiao Pill.

Explore the full profile